The 2C family is a group of synthetic psychedelics used as designer drugs and MDMA analogs. They were first synthesized by chemist Alexander Shulgin in the 1970s. Since then they have been used to circumvent legal bans on MDMA. Many members of the group, like 2C-I and 2C-B cause stimulation, euphoria, increased heart rate, color enhancement, and hallucinations. Different members of the 2C family have different effective doses, and they can be hard to tell apart. This can lead to overdose in cases of mistaken identity.
2C-B was synthesized from 2,5-dimethoxybenzaldehyde by Alexander Shulgin in 1974. It first saw use among the psychiatric community as an aid during therapy. 2C-B was first sold commercially as a purported aphrodisiac under the trade name “Erox”, which was manufactured by the German pharmaceutical company Drittewelle. For several years, it was available as tablets in Dutch smart shops under the name “Nexus”.
Patterns of use
2C-B first became popularized in the United States as a short-lived substitute for the street drug Ecstasy when MDMA became illegal in 1985. Many 2C-B users are young adults who attend raves. Though 2C-B is still used in the rave subculture, commonly mistaken for and/or sold as Ecstasy, its intentional use has become more common in the 2000s. Since 2013, 2C-B has emerged as the drug of choice for club drug users in Colombia.
Toxicity and dosage
The September 1998 issue of the Journal of Analytical Toxicology reported that very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-B. The relationship between its use and death are unknown. The common oral recreational dose is around 15–25 mg, at which visual and auditory effects are experienced. Severe adverse reactions are extremely rare, but use of 2C-B has been linked to significant brain injury in one case where the dosage was unknown, and the purity of the chemical was not verified.
10grams, 15grams, 3grams, 5grams